quinoxalines has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, G; Jiang, ZG; Yue, TL | 1 |
| Fox-Robichaud, A; Kubes, P; Payne, D | 1 |
| Feijge, MA; Heemskerk, JW; Keularts, IM; van Gorp, RM; Vuist, WM | 1 |
| Brouckaert, P; Buys, E; Cauwels, A; Janssen, B; Sips, P | 1 |
| Dermon, C; Panagis, L; Prokosch, V; Thanos, S; Volk, GF | 1 |
| Demopoulos, CA; Emmanouilidou, E; Machalia, C; Margariti, A; Nika, MC; Papakonstantinou, VD; Philippopoulos, AI; Schnakenburg, G; Stamatakis, GM; Thomaidis, NS | 1 |
6 other study(ies) available for quinoxalines and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Platelet-activating factor inhibits excitatory transmission in rat neostriatum.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Azepines; Glutamates; Glutamic Acid; Neostriatum; Neural Inhibition; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinoxalines; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1993 |
Inhaled NO reaches distal vasculatures to inhibit endothelium- but not leukocyte-dependent cell adhesion.
Topics: Administration, Inhalation; Animals; Capillary Permeability; Cats; Cell Adhesion; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Hydrogen Peroxide; Leukocytes; Leukotriene B4; Lung; Microscopy, Video; Nitric Oxide; Oxadiazoles; Oxidants; Oxidative Stress; P-Selectin; Platelet Activating Factor; Quinoxalines | 1999 |
alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels.
Topics: Adrenergic alpha-Agonists; Aspirin; Blood Platelets; Brimonidine Tartrate; Calcium; Calcium Chloride; Carbazoles; Cyclic AMP; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Epinephrine; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Models, Biological; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandins E; Pyrroles; Quinoxalines; Receptors, Adrenergic, alpha-2; Stimulation, Chemical; Thapsigargin; Thimerosal; Thrombin; Time Factors | 2000 |
Anaphylactic shock depends on PI3K and eNOS-derived NO.
Topics: Anaphylaxis; Animals; Blood Pressure; Cardiovascular Diseases; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Quinoxalines; Serum Albumin, Bovine; Transcription, Genetic | 2006 |
Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Autoradiography; Axons; Brimonidine Tartrate; Clonidine; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Fluorescent Antibody Technique, Indirect; Glaucoma; Glial Fibrillary Acidic Protein; Optic Nerve Injuries; Organ Culture Techniques; Platelet Activating Factor; Protein Disulfide-Isomerases; Proteomics; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Laminin; Retina; Retinal Degeneration; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Coordination Complexes; Dimethyl Sulfoxide; HEK293 Cells; HeLa Cells; Humans; Inflammation Mediators; Ligands; Platelet Activating Factor; Platelet Aggregation; Quinoxalines; Rabbits; Thrombin; Transition Elements | 2023 |